A 30-year-old woman comes to the physician for a pelvic examination and Pap smear. Menses have occurred at regular 28-day intervals since menarche at the age of 11 years and last for 5 days. The first day of her last menstrual period was 3 weeks ago. She is sexually active with her husband and takes oral contraceptive pills. Her last Pap smear was 3 years ago. She has never had a mammography. Her mother and maternal aunt died of breast cancer. Pelvic examination shows a normal vagina and cervix. Bimanual examination shows a normal-sized uterus and no palpable adnexal masses. Which of the following health maintenance recommendations is most appropriate at this time?
Q72
A 17-year-old girl presents to her pediatrician for a wellness visit. She currently feels well but is concerned that she has not experienced menarche. She reports to recently developing headaches and describes them as pulsating, occurring on the left side of her head, associated with nausea, and relieved by ibuprofen. She is part of the school’s rugby team and competitively lifts weights. She is currently sexually active and uses condoms infrequently. She denies using any forms of contraception or taking any medications. Her temperature is 98.6°F (37°C), blood pressure is 137/90 mmHg, pulse is 98/min, and respirations are 17/min. On physical exam, she has normal breast development and pubic hair is present. A pelvic exam is performed. A urine hCG test is negative. Which of the following is the best next step in management?
Q73
A 24-year-old woman calls her gynecologist complaining of vaginal odor and vaginal discharge. She had an intrauterine device placed last year and does not use condoms with her boyfriend. She has a past medical history of constipation and depression. She recently was successfully treated for a urinary tract infection with a 2-day course of antibiotics. Physical exam demonstrates an off-white vaginal discharge and a strong odor. Pelvic exam demonstrates an absence of cervical motion tenderness and no adnexal tenderness. Which of the following is the most likely diagnosis?
Q74
A 19-year-old woman presents for a sports physical. She says she feels healthy and has no concerns. Past medical history is significant for depression and seasonal allergies. Current medications are fluoxetine and oral estrogen/progesterone contraceptive pills. Family history is significant for a sister with polycystic ovarian syndrome (PCOS). The patient denies current or past use of alcohol, recreational drugs, or smoking. She reports that she has been on oral birth control pills since age 14 and uses condoms inconsistently. No history of STDs. She is sexually active with her current boyfriend, who was treated for chlamydia 2 years ago. She received and completed the HPV vaccination series starting at age 11. Her vital signs include: temperature 36.8°C (98.2°F), pulse 97/min, respiratory rate 16/min, blood pressure 120/75 mm Hg. Physical examination is unremarkable. Which of the following are the recommended guidelines for cervical cancer screening for this patient at this time?
Q75
A 22-year-old woman comes to the physician because of a 1-month history of a light greenish, milky discharge from both breasts. There is no mastalgia. She has hypothyroidism and migraine headaches. Her mother has breast cancer and is currently undergoing chemotherapy. Menses occur at regular 28-day intervals with moderate flow; her last menstrual period was 1 week ago. Current medications include levothyroxine and propranolol. She appears anxious. Her temperature is 37.1°C (98.78F), pulse is 82/min, and blood pressure is 116/72 mm Hg. The lungs are clear to auscultation. Breast examination is unremarkable. Pelvic examination shows a normal vagina and cervix. Serum studies show:
Thyroid-stimulating hormone 3.5 μU/mL
Progesterone 0.7 ng/mL (Follicular phase: N < 3)
Prolactin 18 ng/mL
Follicle-stimulating hormone 20 mIU/mL
A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?
Q76
A 32-year-old woman presents to her gynecologist for an annual visit. She is currently sexually active with 3 men and reports the consistent use of condoms. She denies abnormal vaginal odor, discharge, or dysuria. A routine Pap test is performed, which shows atypical squamous cells of undetermined significance (ASC-US). Her last Pap test was normal. A reflex human papillomavirus (HPV) test is negative. What is the best next step in the management of this patient?
Q77
A 65-year-old G2P2 presents to her physician for a routine gynecologic check-up. She has been menopausal since 54 years of age, but has not been on hormone replacement therapy. Both pregnancies and deliveries were uneventful. Her husband has been her only sexual partner for the past 30 years. At 45 years of age she underwent a myomectomy for a submucosal uterine fibroid. She has never had any menstrual cycle disturbances. She does not smoke cigarettes and drinks alcohol occasionally. She has had normal Pap smears for the past 30 years. She also had HPV screening 5 years ago with the Pap smear. The co-test results were negative. Her Pap smear at 42 years of age showed a low-grade intraepithelial lesion, but the colposcopy was normal, and the subsequent Pap smear were normal. The screening tests obtained at the current presentation show the following results:
Pap test HPV test
Specimen adequacy: satisfactory for evaluation
Interpretation: negative for intraepithelial lesion or malignancy
Comments: atrophic cellular pattern
negative
Which of the following would be the most appropriate consideration regarding further screening of this patient?
Q78
A 38-year-old woman undergoes a diagnostic hysteroscopy for a 6-month history of small volume intermenstrual bleeding with no other complaints. There is no history of pelvic pain, painful intercourse, or vaginal discharge other than blood. During the procedure, a red beefy pedunculated mass is seen arising from the endometrium of the anterior wall of the uterus that has well-demarcated borders. This mass is resected and sent for histopathological examination. Which of the following is the most likely diagnosis?
Q79
A 27-year-old woman comes to the physician for a routine health maintenance examination. She feels well. She had a chlamydia infection at the age of 22 years that was treated. Her only medication is an oral contraceptive. She has smoked one pack of cigarettes daily for 6 years. She has recently been sexually active with 3 male partners and uses condoms inconsistently. Her last Pap test was 4 years ago and results were normal. Physical examination shows no abnormalities. A Pap test shows atypical squamous cells of undetermined significance. Which of the following is the most appropriate next step in management?
Q80
A 28-year-old woman presents to an outpatient clinic for a routine gynecologic examination. She is concerned about some swelling on the right side of her vagina. She senses that the right side is larger than the left and complains that sometimes that area itches and there is a dull ache. She denies any recent travel or history of trauma. She mentions that she is sexually active in a monogamous relationship with her husband; they use condoms inconsistently. On physical examination her vital signs are normal. Examination of the pelvic area reveals a soft, non-tender, mobile mass that measures approximately 2 cm in the greatest dimension at the 8 o’clock position on the right side of the vulva, just below the vaginal wall. Which of the following is the most likely diagnosis?
Screening tests US Medical PG Practice Questions and MCQs
Question 71: A 30-year-old woman comes to the physician for a pelvic examination and Pap smear. Menses have occurred at regular 28-day intervals since menarche at the age of 11 years and last for 5 days. The first day of her last menstrual period was 3 weeks ago. She is sexually active with her husband and takes oral contraceptive pills. Her last Pap smear was 3 years ago. She has never had a mammography. Her mother and maternal aunt died of breast cancer. Pelvic examination shows a normal vagina and cervix. Bimanual examination shows a normal-sized uterus and no palpable adnexal masses. Which of the following health maintenance recommendations is most appropriate at this time?
A. Pap smear and human papillomavirus testing now and every year, mammography at age 40
B. Pap smear only every year, mammography at age 50
C. Pap smear and human papillomavirus testing now and every 5 years, mammography at age 40 (Correct Answer)
D. Pap smear and human papillomavirus testing now and every year, mammography at age 65
E. Pap smear every 5 years, mammography at age 40
Explanation: ***Pap smear and human papillomavirus testing now and every 5 years, mammography at age 40***
- For women aged 30-65, current guidelines recommend **co-testing with Pap smear and HPV testing every 5 years**, or a Pap smear alone every 3 years. Since her last Pap smear was 3 years ago and she is 30, co-testing is appropriate now, and then every 5 years.
- Given her mother and maternal aunt died of breast cancer, indicating a **strong family history**, initiating mammography screening at age 40 is recommended due to increased risk.
*Pap smear and human papillomavirus testing now and every year, mammography at age 40*
- While a mammography at age 40 is appropriate due to family history, **annual Pap and HPV co-testing is not necessary** for a 30-year-old with normal results; guidelines recommend longer screening intervals.
- More frequent screening than recommended guidelines (e.g., annually) does not provide additional benefit and can lead to unnecessary interventions and anxiety.
*Pap smear only every year, mammography at age 50*
- **Annual Pap smears are not recommended** for women aged 30-65; guidelines suggest every 3 years for Pap alone.
- Delaying mammography until age 50 is inappropriate for a woman with a **strong family history of breast cancer**, as earlier screening is indicated.
*Pap smear and human papillomavirus testing now and every year, mammography at age 65*
- **Annual Pap and HPV co-testing is not supported by current guidelines** for women in this age group; longer intervals are recommended.
- Initiating mammography at age 65 would be **too late** for a woman with a significant family history of breast cancer; earlier screening is crucial for risk management.
*Pap smear every 5 years, mammography at age 40*
- While mammography at age 40 is appropriate due to family history, a **Pap smear every 5 years without HPV co-testing** is less preferred for women aged 30-65 according to current guidelines, which favor co-testing every 5 years or Pap alone every 3 years.
- Relying solely on a Pap smear every 5 years might miss potential issues that HPV co-testing could detect, especially since co-testing is the preferred method for this age group.
Question 72: A 17-year-old girl presents to her pediatrician for a wellness visit. She currently feels well but is concerned that she has not experienced menarche. She reports to recently developing headaches and describes them as pulsating, occurring on the left side of her head, associated with nausea, and relieved by ibuprofen. She is part of the school’s rugby team and competitively lifts weights. She is currently sexually active and uses condoms infrequently. She denies using any forms of contraception or taking any medications. Her temperature is 98.6°F (37°C), blood pressure is 137/90 mmHg, pulse is 98/min, and respirations are 17/min. On physical exam, she has normal breast development and pubic hair is present. A pelvic exam is performed. A urine hCG test is negative. Which of the following is the best next step in management?
A. Serum testosterone
B. Serum T3 and T4
C. Serum estradiol
D. MRI of the head
E. Pelvic ultrasound (Correct Answer)
Explanation: ***Pelvic ultrasound***
- A pelvic ultrasound is the **best initial step** to visualize the anatomy of the reproductive organs and rule out structural abnormalities like **Müllerian agenesis** or an imperforate hymen, which could explain primary amenorrhea despite normal secondary sexual characteristics.
- Given the patient's **primary amenorrhea** (absence of menarche by age 15 with secondary sexual characteristics) and active sexual life, a pelvic ultrasound can also help identify potential abnormalities such as a **cryptomenorrhea** due to outflow tract obstruction.
*MRI of the head*
- While an MRI of the head might be considered later to evaluate for **hypothalamic or pituitary causes** (e.g., tumors like craniopharyngioma or prolactinoma) of primary amenorrhea, it is not the initial imaging step.
- The patient's headaches, though concerning for migraine, are likely **unrelated** to her primary amenorrhea at this stage without other neurological signs or significantly elevated prolactin levels.
*Serum estradiol*
- Measuring serum estradiol levels is important in evaluating primary amenorrhea to assess **gonadal function** and differentiate between hypogonadotropic and hypergonadotropic hypogonadism.
- However, direct visualization of the reproductive tract and ruling out **anatomical obstructions** is typically a more immediate and critical first step in a patient with normal secondary sexual development.
*Serum T3 and T4*
- Thyroid hormone levels (T3 and T4) are assessed to rule out **thyroid dysfunction** (hypothyroidism or hyperthyroidism) as a cause of menstrual irregularities or primary amenorrhea.
- While thyroid issues can affect menstruation, they are generally not the most common or immediate cause to investigate in a patient with **normal secondary sexual characteristics** and no other overt symptoms of thyroid disease.
*Serum testosterone*
- Serum testosterone levels are useful in evaluating for **hyperandrogenism**, which might be seen in conditions like **Polycystic Ovary Syndrome (PCOS)** or **androgen-secreting tumors**.
- However, in this patient with normal breast development and pubic hair but no menarche, the initial focus is on confirming the presence of a **uterus and ovaries** and ruling out anatomical obstructions, rather than immediately investigating androgen excess.
Question 73: A 24-year-old woman calls her gynecologist complaining of vaginal odor and vaginal discharge. She had an intrauterine device placed last year and does not use condoms with her boyfriend. She has a past medical history of constipation and depression. She recently was successfully treated for a urinary tract infection with a 2-day course of antibiotics. Physical exam demonstrates an off-white vaginal discharge and a strong odor. Pelvic exam demonstrates an absence of cervical motion tenderness and no adnexal tenderness. Which of the following is the most likely diagnosis?
A. Inflammatory bacterial infection
B. Pregnancy within the uterine tubes
C. Physiologic discharge secondary to normal hormonal fluctuations
D. Insufficiently treated urinary tract infection
E. Bacterial vaginosis (Correct Answer)
Explanation: **Bacterial vaginosis**
- The symptoms of **vaginal odor** and **off-white discharge** are classic for **bacterial vaginosis**, a common imbalance of vaginal flora.
- The absence of **cervical motion tenderness** and **adnexal tenderness** differentiates it from more serious inflammatory conditions like PID.
*Inflammatory bacterial infection*
- An inflammatory bacterial infection (e.g., cervicitis, salpingitis, or PID) would typically present with **cervical motion tenderness**, **adnexal tenderness**, or fever, which are absent here.
- While an IUD can increase the risk of PID, the clinical presentation does not support this diagnosis.
*Pregnancy within the uterine tubes*
- **Ectopic pregnancy** would present with symptoms such as **abdominal pain**, **vaginal bleeding**, or signs of shock, and would not typically manifest with vaginal odor and discharge.
- There is no mention of a missed period or positive pregnancy test.
*Physiologic discharge secondary to normal hormonal fluctuations*
- While normal **hormonal fluctuations** can cause changes in vaginal discharge, they typically do not lead to a **strong odor**, particularly the characteristic "fishy" odor associated with bacterial vaginosis.
- Physiologic discharge is usually clear or whitish, without a foul smell.
*Insufficiently treated urinary tract infection*
- An **unresolved UTI** would primarily present with urinary symptoms such as **dysuria, frequency, and urgency**, not vaginal odor and discharge.
- The patient was recently treated for a UTI and her current symptoms are distinctly vaginal.
Question 74: A 19-year-old woman presents for a sports physical. She says she feels healthy and has no concerns. Past medical history is significant for depression and seasonal allergies. Current medications are fluoxetine and oral estrogen/progesterone contraceptive pills. Family history is significant for a sister with polycystic ovarian syndrome (PCOS). The patient denies current or past use of alcohol, recreational drugs, or smoking. She reports that she has been on oral birth control pills since age 14 and uses condoms inconsistently. No history of STDs. She is sexually active with her current boyfriend, who was treated for chlamydia 2 years ago. She received and completed the HPV vaccination series starting at age 11. Her vital signs include: temperature 36.8°C (98.2°F), pulse 97/min, respiratory rate 16/min, blood pressure 120/75 mm Hg. Physical examination is unremarkable. Which of the following are the recommended guidelines for cervical cancer screening for this patient at this time?
A. Cytology (pap smear) and HPV DNA co-testing every 3 years
B. Cytology (pap smear) every 3 years
C. Cytology (pap smear) annually
D. Cytology (pap smear) and HPV DNA co-testing every 5 years
E. No cervical cancer screening is indicated at this time (Correct Answer)
Explanation: ***No cervical cancer screening is indicated at this time***
- Current guidelines recommend initiating **cervical cancer screening** at age 21, regardless of sexual activity initiation.
- The patient is 19 years old, therefore, screening is not yet indicated per standard recommendations.
*Cytology (pap smear) and HPV DNA co-testing every 3 years*
- This option is incorrect because **co-testing** with cytology and HPV DNA is generally recommended for women aged 30-65 years, not for women under 21.
- While cytology every 3 years is a recommendation for women 21-29, co-testing is not the primary recommendation in this age group, and the patient is below the screening age.
*Cytology (pap smear) every 3 years*
- This screening interval is recommended for women aged 21-29 years, but the patient is currently 19 years old.
- Initiating screening earlier than 21 years is not recommended due to the high incidence of **transient HPV infections** and low risk of cervical cancer in younger individuals.
*Cytology (pap smear) annually*
- **Annual Pap smears** are no longer recommended for routine screening; guidelines have shifted to longer intervals due to the slow progression of cervical cancer and high rates of HPV clearance.
- Even if screening were indicated, annual cytology is not the current recommendation for any age group, especially not for a 19-year-old.
*Cytology (pap smear) and HPV DNA co-testing every 5 years*
- This screening strategy (**co-testing every 5 years**) is recommended for women aged 30-65 years.
- This patient is only 19 years old, making this recommendation inappropriate for her age.
Question 75: A 22-year-old woman comes to the physician because of a 1-month history of a light greenish, milky discharge from both breasts. There is no mastalgia. She has hypothyroidism and migraine headaches. Her mother has breast cancer and is currently undergoing chemotherapy. Menses occur at regular 28-day intervals with moderate flow; her last menstrual period was 1 week ago. Current medications include levothyroxine and propranolol. She appears anxious. Her temperature is 37.1°C (98.78F), pulse is 82/min, and blood pressure is 116/72 mm Hg. The lungs are clear to auscultation. Breast examination is unremarkable. Pelvic examination shows a normal vagina and cervix. Serum studies show:
Thyroid-stimulating hormone 3.5 μU/mL
Progesterone 0.7 ng/mL (Follicular phase: N < 3)
Prolactin 18 ng/mL
Follicle-stimulating hormone 20 mIU/mL
A urine pregnancy test is negative. Which of the following is the most appropriate next step in management?
A. MRI of the head
B. Ultrasound of both breasts
C. Reassurance and recommend avoidance of nipple stimulation (Correct Answer)
D. Mammogram of both breasts
E. Galactography of both breasts
Explanation: ***Reassurance and recommend avoidance of nipple stimulation***
- The patient's **prolactin level (18 ng/mL)** is within the normal range (<25 ng/mL for non-pregnant women), making further diagnostic workup for hyperprolactinemia unnecessary.
- Given the normal prolactin, regular menses, negative pregnancy test, and unremarkable breast exam, the galactorrhea is likely **physiologic** and exacerbated by nipple stimulation or anxiety.
*MRI of the head*
- This would be indicated if the patient had **hyperprolactinemia (prolactin >25 ng/mL)** to rule out a pituitary adenoma.
- Since her prolactin level is normal, a pituitary MRI is not warranted at this time.
*Ultrasound of both breasts*
- Breast imaging (ultrasound or mammogram) is usually indicated for **palpable masses**, **bloody or unilateral nipple discharge**, or signs suspicious for malignancy.
- The patient has bilateral, milky discharge with no masses, making imaging less urgent.
*Mammogram of both breasts*
- A mammogram is typically performed in women over 40 for **screening** or for evaluation of suspicious breast symptoms, especially those suggestive of malignancy.
- This patient is 22 years old and presents with bilateral, non-bloody discharge, not a mass, and her risk factors are primarily for physiological galactorrhea.
*Galactography of both breasts*
- Galactography (ductography) is typically performed for cases of **unilateral, bloody, or serous nipple discharge** to identify intraductal pathologies like papillomas or carcinomas.
- Her discharge is bilateral and milky, which is not an indication for galactography.
Question 76: A 32-year-old woman presents to her gynecologist for an annual visit. She is currently sexually active with 3 men and reports the consistent use of condoms. She denies abnormal vaginal odor, discharge, or dysuria. A routine Pap test is performed, which shows atypical squamous cells of undetermined significance (ASC-US). Her last Pap test was normal. A reflex human papillomavirus (HPV) test is negative. What is the best next step in the management of this patient?
A. Routine screening: repeat Pap test every 3 years
B. Cervical biopsy
C. Repeat cytology and HPV testing in 3 years (Correct Answer)
D. Excisional treatment
E. Colposcopy
Explanation: ***Repeat cytology and HPV testing in 3 years***
- For women aged 30 years and older with **atypical squamous cells of undetermined significance (ASC-US)** and a **negative reflex HPV test**, the recommended follow-up is to repeat co-testing (cytology and HPV) in 3 years.
- This approach is based on the low likelihood of underlying high-grade cervical intraepithelial neoplasia (CIN) when HPV is negative, allowing for a longer interval before re-evaluation.
*Routine screening: repeat Pap test every 3 years*
- This option is incorrect because standard routine screening for women aged 30-65 with a **normal Pap test** and **negative HPV test (co-testing)** is every 5 years, not every 3 years.
- While repeating in 3 years is part of management for ASC-US with negative HPV, this wording incorrectly implies simple routine screening rather than targeted follow-up.
*Cervical biopsy*
- A **cervical biopsy** is a more invasive procedure generally reserved for cases with a higher suspicion of high-grade lesions, such as persistent **high-risk HPV infection** or **high-grade squamous intraepithelial lesion (HSIL)** found on cytology.
- Given the negative HPV test and ASC-US result, a biopsy is not warranted as the initial next step.
*Excisional treatment*
- **Excisional treatment** (e.g., LEEP or cold knife conization) is used to remove **pre-cancerous** or cancerous cervical lesions, typically after a confirmed diagnosis of **high-grade CIN** or cancer through colposcopy and biopsy.
- This is an overly aggressive and inappropriate initial step for ASC-US with a negative HPV test.
*Colposcopy*
- **Colposcopy** is indicated when there is a higher suspicion of significant cervical changes, such as with **positive high-risk HPV**, **ASC-US with positive HPV**, or detection of **low-grade squamous intraepithelial lesion (LSIL)** or higher on cytology.
- In this case, the **negative HPV test** reduces the immediate concern for high-grade disease, making colposcopy unnecessary as the initial management.
Question 77: A 65-year-old G2P2 presents to her physician for a routine gynecologic check-up. She has been menopausal since 54 years of age, but has not been on hormone replacement therapy. Both pregnancies and deliveries were uneventful. Her husband has been her only sexual partner for the past 30 years. At 45 years of age she underwent a myomectomy for a submucosal uterine fibroid. She has never had any menstrual cycle disturbances. She does not smoke cigarettes and drinks alcohol occasionally. She has had normal Pap smears for the past 30 years. She also had HPV screening 5 years ago with the Pap smear. The co-test results were negative. Her Pap smear at 42 years of age showed a low-grade intraepithelial lesion, but the colposcopy was normal, and the subsequent Pap smear were normal. The screening tests obtained at the current presentation show the following results:
Pap test HPV test
Specimen adequacy: satisfactory for evaluation
Interpretation: negative for intraepithelial lesion or malignancy
Comments: atrophic cellular pattern
negative
Which of the following would be the most appropriate consideration regarding further screening of this patient?
A. Pap smears should be repeated every 5 years
B. The Pap smear should be repeated every 3 years
C. The Pap smear should be repeated after 1 week of vaginal estrogen cream application, and a definitive decision should be made based on the results of the re-testing
D. Discontinuing screening in this patient should be considered (Correct Answer)
E. Pap smear and HPV co-testing should be performed every 5 years
Explanation: ***Discontinuing screening in this patient should be considered***
- Current guidelines recommend discontinuing **cervical cancer screening** (Pap tests and HPV co-testing) in individuals aged 65 or older with an adequate history of **negative screening results**.
- An adequate negative screening history typically includes three consecutive negative Pap tests or two consecutive negative co-tests within the last 10 years, with the most recent test performed within the past 3 to 5 years, and no history of **CIN2/3** or higher for the past 25 years. This patient meets these criteria.
*Pap smears should be repeated every 5 years*
- This option reflects the interval for **co-testing (Pap + HPV)** in younger, average-risk women, but not solely for Pap smears, nor for women over 65 with a negative screening history.
- Continuing any form of routine screening past age 65 without specific indications goes against current **ACOG/ASCCP guidelines** for cessation of screening.
*The Pap smear should be repeated every 3 years*
- This interval is typically recommended for **Pap smear-only screening** in average-risk individuals aged 21-65.
- It does not apply to this patient's age and history, which would support discontinuing screening.
*The Pap smear should be repeated after 1 week of vaginal estrogen cream application, and a definitive decision should be made based on the results of the re-testing*
- While an **atrophic cellular pattern** can sometimes obscure interpretation, the current Pap smear was interpreted as "satisfactory for evaluation" and "negative for intraepithelial lesion or malignancy."
- Using **vaginal estrogen cream** might be considered if the smear were "unsatisfactory" due to severe atrophy, but it is not indicated here given the clear negative result and sufficient screening history.
*Pap smear and HPV co-testing should be performed every 5 years*
- This is the recommended interval for **co-testing** in average-risk individuals aged 30-65.
- However, for women over 65 with an adequate negative screening history, guidelines recommend **cessation of screening**, not continued co-testing.
Question 78: A 38-year-old woman undergoes a diagnostic hysteroscopy for a 6-month history of small volume intermenstrual bleeding with no other complaints. There is no history of pelvic pain, painful intercourse, or vaginal discharge other than blood. During the procedure, a red beefy pedunculated mass is seen arising from the endometrium of the anterior wall of the uterus that has well-demarcated borders. This mass is resected and sent for histopathological examination. Which of the following is the most likely diagnosis?
A. Endometrial hyperplasia
B. Endometrial polyp (Correct Answer)
C. Uterine leiomyoma
D. Endometrial carcinoma
E. Uterine adenomyosis
Explanation: ***Endometrial polyp***
- The description of a **red, beefy, pedunculated mass with well-demarcated borders** arising from the **endometrium**, causing **intermenstrual bleeding**, is highly characteristic of an endometrial polyp.
- Endometrial polyps are common benign growths that often present with **abnormal uterine bleeding**, including intermenstrual spotting.
*Endometrial hyperplasia*
- Endometrial hyperplasia is characterized by an **overgrowth of the endometrial glandular and stromal components**, not typically forming a single pedunculated mass.
- While it can cause abnormal uterine bleeding, the **gross appearance** described (pedunculated mass) is not typical.
*Uterine leiomyoma*
- Leiomyomas (fibroids) are **benign tumors of the myometrium**; if submucosal, they can protrude into the endometrial cavity, but they are typically described as **firm, whitish, and not typically "red and beefy."**
- They tend to be **paler** and more fibrous in consistency compared to the vascular appearance of a polyp.
*Endometrial carcinoma*
- Endometrial carcinoma can present with abnormal uterine bleeding, but it often appears as a **more irregular, friable, or infiltrative mass** rather than a well-demarcated, pedunculated polyp.
- While a polyp can occasionally harbor carcinoma, the primary description alone points more strongly to a benign polyp.
*Uterine adenomyosis*
- Adenomyosis involves the presence of **ectopic endometrial glands and stroma within the myometrium**, leading to a diffusely enlarged uterus, often painful, not a focal pedunculated mass.
- Its symptoms include **heavy menstrual bleeding and dysmenorrhea**, and it's not visualized as a discrete endometrial mass on hysteroscopy in the manner described.
Question 79: A 27-year-old woman comes to the physician for a routine health maintenance examination. She feels well. She had a chlamydia infection at the age of 22 years that was treated. Her only medication is an oral contraceptive. She has smoked one pack of cigarettes daily for 6 years. She has recently been sexually active with 3 male partners and uses condoms inconsistently. Her last Pap test was 4 years ago and results were normal. Physical examination shows no abnormalities. A Pap test shows atypical squamous cells of undetermined significance. Which of the following is the most appropriate next step in management?
A. Repeat cytology in 6 months
B. Perform laser ablation
C. Perform loop electrosurgical excision procedure
D. Perform HPV testing (Correct Answer)
E. Perform cervical biopsy
Explanation: ***Perform HPV testing***
- For women aged 25-29 with **Atypical Squamous Cells of Undetermined Significance (ASC-US)**, **HPV co-testing** is the preferred next step to risk-stratify for high-grade lesions.
- If **HPV is positive**, the patient should proceed to **colposcopy**; if HPV is negative, she can return to routine screening.
*Repeat cytology in 6 months*
- This approach is typically recommended for adolescents (age <21) with ASC-US or for women aged 21-24 where HPV testing is often not performed due to the high rate of transient HPV infections.
- For women aged ≥25 years with ASC-US, **reflex HPV testing** or **HPV co-testing** (if not done with the initial Pap) is generally preferred over repeat cytology alone.
*Perform laser ablation*
- **Laser ablation** is a treatment for **high-grade cervical intraepithelial neoplasia (CIN2/3)** identified after colposcopy and biopsy, not for initial ASC-US findings.
- Initiating a destructive procedure without further diagnostic evaluation would be premature and over-treatment for ASC-US.
*Perform loop electrosurgical excision procedure*
- **LEEP (loop electrosurgical excision procedure)** is a **diagnostic and therapeutic procedure** typically reserved for confirmed **high-grade CIN (CIN2 or CIN3)** or adenocarcinoma in situ.
- It is an invasive procedure and not appropriate as the initial management step for an ASC-US Pap result.
*Perform cervical biopsy*
- A **cervical biopsy** is performed during a **colposcopy** if abnormal areas are identified, usually following a positive HPV test or higher-grade abnormal cytology (e.g., LSIL, HSIL).
- ASC-US alone does not automatically warrant an immediate colposcopy and biopsy without prior **HPV risk stratification**.
Question 80: A 28-year-old woman presents to an outpatient clinic for a routine gynecologic examination. She is concerned about some swelling on the right side of her vagina. She senses that the right side is larger than the left and complains that sometimes that area itches and there is a dull ache. She denies any recent travel or history of trauma. She mentions that she is sexually active in a monogamous relationship with her husband; they use condoms inconsistently. On physical examination her vital signs are normal. Examination of the pelvic area reveals a soft, non-tender, mobile mass that measures approximately 2 cm in the greatest dimension at the 8 o’clock position on the right side of the vulva, just below the vaginal wall. Which of the following is the most likely diagnosis?
A. Squamous cell carcinoma
B. Vulvar hematoma
C. Molluscum contagiosum
D. Bartholin duct cyst (Correct Answer)
E. Condylomata acuminata
Explanation: ***Bartholin duct cyst***
- A **Bartholin duct cyst** presents as a soft, non-tender, mobile mass in the **inferior vulva (4 or 8 o’clock position)**, consistent with the location of the Bartholin glands.
- Symptoms like mild irritation, itching, or a dull ache are common, and the lesion typically represents obstruction of the **Bartholin duct** rather than a serious infection or malignancy.
*Squamous cell carcinoma*
- **Squamous cell carcinoma** of the vulva usually presents as an ulcerated, firm, or raised lesion, often associated with pain, bleeding, or persistent itching, which is not described.
- While it can occur in sexually active women, the mass described is **soft, mobile, and non-tender**, making cancer less likely given these characteristics.
*Vulvar hematoma*
- A **vulvar hematoma** results from trauma and presents as a painful, firm, and often discolored swelling due to blood accumulation.
- The patient denies trauma and the mass is described as **soft and non-tender**, ruling out a hematoma.
*Molluscum contagiosum*
- **Molluscum contagiosum** manifests as small, discrete, flesh-colored, dome-shaped papules with a characteristic **umbilicated center**.
- The described lesion is a **2 cm mobile mass**, not a small papule, making molluscum contagiosum an unlikely diagnosis.
*Condylomata acuminata*
- **Condylomata acuminata** (genital warts) are caused by HPV and appear as warty, cauliflower-like growths.
- The mass in the description is a **smooth, mobile, and soft cyst**, not a verrucous lesion, differentiating it from condylomata.